Finzati - Logo
PBH logo

Prestige Consumer Healthcare Inc.

PBHMedical - Distribution
$0.00
0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
FAVORABLE PROFILEAttractiveConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$2.58B
Growth
18.1%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 17.5%Positive free cash flow · 5.25Consistent free cash flow · 5/5Reasonable earnings multiple · 15.09Manageable debt level · 0.55
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 12:56 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.00
Change0.00%
Market Cap$2.58B
52W Range42.62 - 72.89
Beta0.35
Gross Margin52.78%
Oper. Margin28.42%
Profit Margin17.48%
Debt/Eq0.55
Current Ratio3.57
Quick Ratio2.25
Revenue 5Y18.09%

Investment DNA

How strong this company looks for long-term investors

79
out of 100
Business Quality
Margins, moat, returns
84/100
Financial Strength
Debt, cash, stability
87/100
Growth Potential
Revenue and expansion
37/100
Price Attractiveness
Cheap or expensive today
83/100
Why this score
Stable or improving margins · 17.5%Positive free cash flow · 5.25Consistent free cash flow · 5/5Reasonable earnings multiple · 15.09Manageable debt level · 0.55Healthy liquidity · 3.57

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-07
Low
$66.00
Mean
$81.67
Median
$86.00
High
$93.00

Company Overview

IPO: 2/10/2005
Industry: Medical - Distribution
P/B i: 1.52
Debt / Equity i: 0.55
Operating Margin: 28.42%
Net Margin: 17.48%
ROE i: -
ROIC: -

Financial Health

Score17 / 20
Debt / Equity: 0.55
Current Ratio: 3.57
Quick Ratio: 2.25
Status: Strong

Insider Transactions

Recent executive and insider activity

BYOM JOHN E
Transaction: 08/04/2026
BUY
Change
+2,981
Price
Not reported
Filing
08/05/2026
Type
BUY
Clark Celeste A.
Transaction: 08/04/2026
BUY
Change
+2,981
Price
Not reported
Filing
08/05/2026
Type
BUY
DArecca James
Transaction: 08/04/2026
BUY
Change
+2,981
Price
Not reported
Filing
08/05/2026
Type
BUY